TY - JOUR
T1 - Montelukast versus inhaled corticosteroids as monotherapy for prevention of asthma: which one is best?
AU - Miceli Sopo, Stefano
AU - Onesimo, Roberta
AU - Radzik, D.
AU - Scala, G.
AU - Cardinale, F.
PY - 2009
Y1 - 2009
N2 - The GINA guidelines (GL)1, the BTS-SIGN GL2, and the paediatric PRACTALL GL3, indicate inhaled corticosteroids (ICS) as the frst choice for controller therapy of paediatric asthma. The authors of BTS-SIGN GL recommended a leukotriene receptor antagonist, if ICS cannot be administered. Montelukast (MLK) is the most commonly used in children. If ICS remain the frst choice, they can be considered the Gold Standard for pharmacological asthma prevention and the value of any alternative treatment must be measured against them, not only against a placebo. Here we will try to shed some light as to which of those two drugs is better according to the present evidence.
AB - The GINA guidelines (GL)1, the BTS-SIGN GL2, and the paediatric PRACTALL GL3, indicate inhaled corticosteroids (ICS) as the frst choice for controller therapy of paediatric asthma. The authors of BTS-SIGN GL recommended a leukotriene receptor antagonist, if ICS cannot be administered. Montelukast (MLK) is the most commonly used in children. If ICS remain the frst choice, they can be considered the Gold Standard for pharmacological asthma prevention and the value of any alternative treatment must be measured against them, not only against a placebo. Here we will try to shed some light as to which of those two drugs is better according to the present evidence.
KW - asthma
KW - asthma
UR - http://hdl.handle.net/10807/31847
U2 - 10.1016/S0301-0546(09)70248-4
DO - 10.1016/S0301-0546(09)70248-4
M3 - Article
SN - 0301-0546
VL - 2009
SP - 26
EP - 30
JO - Allergologia et Immunopathologia
JF - Allergologia et Immunopathologia
ER -